It is well known that patients with HNF1A-MODY have the same risk of developing microvascular and macrovascular complications as those with type 1 diabetes and type 2 diabetes [1, 4, 10], especially in cases of poor glycemic control [4]. This evidence concerns the gene HNF1A and type 2 diabetes mellitus.